Huangliang Zheng - Publications

Inhalable PLGA microspheres: Tunable lung retention and systemic exposure via polyethylene glycol modification.

Journal: Acta biomaterialia

Published: August 16, 2020

In vitro-in vivo correlation of inhalable budesonide-loaded large porous particles for sustained treatment regimen of asthma.

Journal: Acta biomaterialia

Published: April 07, 2019

Phospholipid-modified poly(lactide-co-glycolide) microparticles for tuning the interaction with alveolar macrophages: In vitro and in vivo assessment.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: April 02, 2019

Dual-Ligand Modification of PEGylated Liposomes Used for Targeted Doxorubicin Delivery to Enhance Anticancer Efficacy.

Journal: AAPS PharmSciTech

Published: February 27, 2019

Neutrophil-Mediated Delivery of Dexamethasone Palmitate-Loaded Liposomes Decorated with a Sialic Acid Conjugate for Rheumatoid Arthritis Treatment.

Journal: Pharmaceutical research

Published: January 13, 2019

Exhausting tumor associated macrophages with sialic acid-polyethyleneimine-cholesterol modified liposomal doxorubicin for enhancing sarcoma chemotherapy.

Journal: International journal of pharmaceutics

Published: September 11, 2018

Murine RAW264.7 cells as cellular drug delivery carriers for tumor therapy: a good idea?

Journal: Cancer chemotherapy and pharmacology

Published: August 01, 2018

Novel Self-Assembled Ibrutinib-Phospholipid Complex for Potently Peroral Delivery of Poorly Soluble Drugs with pH-Dependent Solubility.

Journal: AAPS PharmSciTech

Published: June 08, 2018

Neutrophil-mediated delivery of pixantrone-loaded liposomes decorated with poly(sialic acid)-octadecylamine conjugate for lung cancer treatment.

Journal: Drug delivery

Published: May 24, 2018